Pharma Clinical Trial Digitization – Companies to Action 2019 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Pharma
Clinical Trial Digitization – Companies to Action, 2019” report
has been added to ResearchAndMarkets.com’s offering.

Despite the term patient centricity gaining currency in the industry,
there is a degree of variability in the approach and strategic
priorities by companies. Digitization is set to play a critical role in
transforming the clinical trial model from traditional, high-cost, and
difficult-to-access centralized settings to more patient-centric and
efficient distributed settings. As the clinical trial industry
transitions to biomarker-based, targeted therapeutics, it demands a
pivotal shift in design focus: from one directed by researchers to one
driven by the needs of patients and their caregivers. Leading
pharmaceutical companies, in particular, are aggressively moving toward
the mixed approach of physical and remote clinical trial settings to
improve patient engagement and justify the value of future personalized
drugs. Furthermore, increasing demand for quality data and novel
endpoints demands clinical trial data management solutions to shift from
fragmented point solutions that sit in silos to integrated eClinical
solutions that provide a single source of truth, optimizing the cost by
eliminating duplicate data entry, reducing on-site verification and
source data verification rate. This entails an evolving vendor ecosystem
of modular cloud-based eClinical solutions with an intuitive user
interface capable of integrating all possible study and eSource data to
optimize clinical trial digital workflows and data management cost and
time.

Research Scope

The research service analyzes the 3 big themes driving clinical trial
digitization and the new vendor ecosystem. The study also highlights
growth opportunities, case studies of notable market developments, key
trends, and investment and collaboration opportunities. Furthermore, the
study provides an analysis of major companies segregated by these top 3
themes, which include:

• Digital Continuity Across Clinical Trial IT Systems: Digital
  continuity provides the framework and transparency required throughout
  the drug’s lifecycle, from discovery to post approval. Leading
  clinical trial IT vendors provide propriety or third-party-hosted
  cloud-based eClinical platforms.
• Patient-centric Remote and Virtual Trial Design: The new pharma era
  breeds customer centricity, innovation, and engagement with patients,
  physicians, and all partners in the healthcare ecosystem.
• Direct-to-patient Home Services: Beyond the technological readiness,
  deployment of remote/virtual clinical trials will heavily rely on DTP
  clinical supplies and logistics services to meet patients and
  caregivers where they are.
• Companies mentioned in the study are Oracle (ClinicalOne), Medidata
  Solutions, Science 37, THREAD Research, Evidation Health, ActiGraph,
  Veeva Systems, Antidote Technologies, Inc., ConsilX, 4G Clinical,
  CliniOps Inc, CRF, Koneska Health, Aparito, Clinerion, TrialBee,
  TriNetX Network, PatientsLikeMe, and Deep 6 AI.

Key Issues Addressed

• What are the growth opportunities in clinical trials digitization
  space? What is the impact of the external environment on this market?
• What are the unique companies that are introducing innovative digital
  solutions in the market?
• How can companies transform clinical trial operations to provide
  much-needed patient-centric trials and efficiencies?
• What are the action plans and what is the potential for growth for
  disruptive and innovative companies in the clinical trials
  digitization space?
• What is the convergence potential of emerging technologies across the
  clinical development value chain (such as mHealth, wearables, AI, IoT,
  and blockchain)?
• How does the future vendor ecosystem for clinical trials look?

For more information about this report visit https://www.researchandmarkets.com/r/aofase

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Clinical
Trials